Plagiocephaly Device First To Avoid Class III Status Via FDAMA Provision
This article was originally published in The Gray Sheet
Executive Summary
Cranial orthosis devices intended to treat severe non-synostotic positional plagiocephaly in infants three to 18 months of age are the first generic device type to avoid default Class III status via Sec. 207 of the FDA Modernization Act.